Drug: TYSABRI Injury: Cognitive disorder Quarter: 2016Q3
Total Records: 42 Number of Pages: 3
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126032421 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160728 | US |
| 126080161 | TYSABRI | Cognitive disorder | BIOGEN | 33.00 YR | F | 0 | 20160729 | CO |
| 126102031 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160801 | US |
| 126131251 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | M | 0 | 20160802 | US |
| 126241601 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160805 | US |
| 126393921 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160810 | US |
| 126418312 | TYSABRI | Cognitive disorder | BIOGEN | 65.46 YR | F | 0 | 20160830 | US |
| 126511102 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160926 | US |
| 126511821 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160815 | US |
| 126531983 | TYSABRI | Cognitive disorder | BIOGEN | 40.12 YR | M | 0 | 20160823 | BR |
| 126581721 | TYSABRI | Cognitive disorder | BIOGEN | 40.58 YR | F | 0 | 20160817 | US |
| 126666131 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160819 | US |
| 126701161 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160821 | US |
| 126790531 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160824 | US |
| 126820021 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160824 | US |
| 127055621 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160901 | US |
| 127098422 | TYSABRI | Cognitive disorder | NOVARTIS | 41.32 YR | M | 0 | 20160916 | JP |
| 127216322 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | F | 0 | 20160926 | US |
| 127233871 | TYSABRI | Cognitive disorder | BIOGEN | 39.11 YR | F | 0 | 20160908 | US |
| 127568671 | TYSABRI | Cognitive disorder | BIOGEN | 0.00 | M | 0 | 20160917 | US |
Total Records: 42 Number of Pages: 3